These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 38146680)

  • 21. Heart Failure Severity Stratification Beyond INTERMACS Profiles: A Step Toward Optimal Left Ventricular Assist Device Timing.
    Cogswell R; Estep JD; Araujo-Gutierrez R; Masotti M; Majaraj V; Teigen L; Schultz J; John R; Martin CM; Trachtenberg B
    ASAIO J; 2021 May; 67(5):554-560. PubMed ID: 33470635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abdominal skeletal muscle mass as a predictor of mortality in Japanese patients undergoing left ventricular assist device implantation.
    Tsuji M; Amiya E; Hatano M; Nitta D; Maki H; Bujo C; Saito A; Hosoya Y; Minatsuki S; Hara T; Nemoto M; Kagami Y; Endo M; Kimura M; Kinoshita O; Nawata K; Morita H; Ono M; Komuro I
    ESC Heart Fail; 2019 Jun; 6(3):526-535. PubMed ID: 30929311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Society of Thoracic Surgeons Intermacs Database Annual Report: Evolving Indications, Outcomes, and Scientific Partnerships.
    Kormos RL; Cowger J; Pagani FD; Teuteberg JJ; Goldstein DJ; Jacobs JP; Higgins RS; Stevenson LW; Stehlik J; Atluri P; Grady KL; Kirklin JK
    Ann Thorac Surg; 2019 Feb; 107(2):341-353. PubMed ID: 30691584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations of body composition parameters with postoperative outcome and perineural tumour invasion after oncological pancreatic resection.
    Mueller TC; Henselmann M; Reischl S; Jaeger C; Trefzer C; Demir IE; Friess H; Martignoni ME
    BMC Surg; 2024 Jun; 24(1):175. PubMed ID: 38835067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
    Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors Associated With Health-Related Quality of Life 2 Years After Left Ventricular Assist Device Implantation: Insights From INTERMACS.
    Grady KL; Fazeli PL; Kirklin JK; Pamboukian SV; White-Williams C
    J Am Heart Assoc; 2021 Jul; 10(14):e021196. PubMed ID: 34238018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel.
    Cushen SJ; Power DG; Murphy KP; McDermott R; Griffin BT; Lim M; Daly L; MacEneaney P; O' Sullivan K; Prado CM; Ryan AM
    Clin Nutr ESPEN; 2016 Jun; 13():e39-e45. PubMed ID: 28531567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in disease-specific versus generic health status measures after left ventricular assist device implantation: Insights from INTERMACS.
    Nassif ME; Spertus JA; Jones PG; Fendler TJ; Allen LA; Grady KL; Arnold SV
    J Heart Lung Transplant; 2017 Nov; 36(11):1243-1249. PubMed ID: 28662987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pectoral muscle mass is not a robust prognostic factor for survival after left ventricular assist device (LVAD) implantation.
    Jenkins FS; Minol JP; Akar T; Yilmaz E; Immohr MB; Dalyanoglu I; Korbmacher B; Aissa J; Boeken U; Lichtenberg A; Akhyari P; Dalyanoglu H
    J Cardiothorac Surg; 2024 Feb; 19(1):76. PubMed ID: 38336743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contemporary Left Ventricular Assist Device Outcomes in an Aging Population: An STS INTERMACS Analysis.
    Emerson D; Chikwe J; Catarino P; Hassanein M; Deng L; Cantor RS; Roach A; Cole R; Esmailian F; Kobashigawa J; Moriguchi J; Kirklin JK
    J Am Coll Cardiol; 2021 Aug; 78(9):883-894. PubMed ID: 34446160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of psoas muscle evaluation on clinical outcomes in patients undergoing left ventricular assist device implantation.
    Minol JP; Dalyanoglu H; Yilmaz E; Dalyanoglu I; Immohr MB; Korbmacher B; Aissa J; Boeken U; Akhyari P; Lichtenberg A; Sugimura Y
    J Cardiovasc Med (Hagerstown); 2022 Sep; 23(9):608-614. PubMed ID: 35994709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Days alive and out of hospital after left ventricular assist device implantation.
    Roth S; M'Pembele R; Stroda A; Voit J; Lurati Buse G; Sixt SU; Westenfeld R; Polzin A; Rellecke P; Tudorache I; Hollmann MW; Boeken U; Akhyari P; Lichtenberg A; Huhn R; Aubin H
    ESC Heart Fail; 2022 Aug; 9(4):2455-2463. PubMed ID: 35513994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ventricular assist device implant in the elderly is associated with increased, but respectable risk: a multi-institutional study.
    Atluri P; Goldstone AB; Kobrin DM; Cohen JE; MacArthur JW; Howard JL; Jessup ML; Rame JE; Acker MA; Woo YJ
    Ann Thorac Surg; 2013 Jul; 96(1):141-7. PubMed ID: 23731606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of body composition on clinical outcomes in people with gastric cancer undergoing radical gastrectomy after neoadjuvant treatment.
    Zhang Y; Li Z; Jiang L; Xue Z; Ma Z; Kang W; Ye X; Liu Y; Jin Z; Yu J
    Nutrition; 2021 May; 85():111135. PubMed ID: 33556785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Derivation and Validation of a Novel Right-Sided Heart Failure Model After Implantation of Continuous Flow Left Ventricular Assist Devices: The EUROMACS (European Registry for Patients with Mechanical Circulatory Support) Right-Sided Heart Failure Risk Score.
    Soliman OII; Akin S; Muslem R; Boersma E; Manintveld OC; Krabatsch T; Gummert JF; de By TMMH; Bogers AJJC; Zijlstra F; Mohacsi P; Caliskan K;
    Circulation; 2018 Feb; 137(9):891-906. PubMed ID: 28847897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The aspartate transaminase/alanine transaminase (DeRitis) ratio predicts mid-term mortality and renal and respiratory dysfunction after left ventricular assist device implantation.
    Pilarczyk K; Carstens H; Heckmann J; Canbay A; Koch A; Pizanis N; Jakob H; Kamler M
    Eur J Cardiothorac Surg; 2017 Oct; 52(4):781-788. PubMed ID: 29156019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictor of early mortality for severe heart failure patients with left ventricular assist device implantation: significance of INTERMACS level and renal function.
    Yoshioka D; Sakaguchi T; Saito S; Miyagawa S; Nishi H; Yoshikawa Y; Fukushima S; Saito T; Daimon T; Ueno T; Kuratani T; Sawa Y
    Circ J; 2012; 76(7):1631-8. PubMed ID: 22484979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary artery pulsatility index predicts right ventricular failure after left ventricular assist device implantation.
    Kang G; Ha R; Banerjee D
    J Heart Lung Transplant; 2016 Jan; 35(1):67-73. PubMed ID: 26212656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Obesity on Ventricular Assist Device Outcomes.
    Jaiswal A; Truby LK; Chichra A; Jain R; Myers L; Patel N; Topkara VK
    J Card Fail; 2020 Apr; 26(4):287-297. PubMed ID: 31618696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Third-generation continuous-flow left ventricular assist devices: a comparative outcome analysis by device type.
    Mihalj M; Heinisch PP; Schober P; Wieser M; Martinelli M; de By TMMH; Schefold JC; Luedi MM; Kadner A; Carrel T; Mohacsi P; Hunziker L; Reineke D
    ESC Heart Fail; 2022 Oct; 9(5):3469-3482. PubMed ID: 35880515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.